Management Team

Welcome to TRIZ Biopharma Innovation, the pioneering company behind Dynamic Self-Adapting Medical Drugs. We have developed a groundbreaking discovery that introduces a new paradigm in precision medicine—personalized and adaptive treatments that evolve in response to each patient’s unique biology. Unlike conventional drugs constrained by genetic variances, our dynamic drugs act like a ‘bunch of skeleton keys,’ ensuring nearly 100% efficacy by adapting to diverse biological targets. This revolutionary methodology integrates over 40 years of innovation, leveraging TRIZ (Theory of Inventive Problem Solving, based on patterns of evolution) in medicine and pharmaceuticals, along with cutting-edge AI technologies, to open the door to a transformative era in medicine. Join us as we redefine the future of healthcare with our visionary approach


Boris Farber


Ph.D, Dr. Sci. Academician
Chief Executive Officer



Artur Martynov


Ph.D., Sc.D., Professor
Executive Vice President for Science



ILya Kleyn M.D.,


M.D., Medical Advisor



Daniel L. Beckles, M.D., Ph.D., FACS, FACC, FCCP


Ph.D, Dr. Sci. Academician
Chief Executive Officer



Eduardo Javier Mascareno Ph.D.


Chief Research Officer



Sonya Farber M.S.


Communication manager



Suzanna Katz Ph.D.


Senior Scientist



Avi Kamelhar MPA


Business Advisor